These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 22486168

  • 1. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
    El-Hussuna A, Andersen J, Bisgaard T, Jess P, Henriksen M, Oehlenschlager J, Thorlacius-Ussing O, Olaison G.
    Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A, Cross RK, Flasar MH.
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [Abstract] [Full Text] [Related]

  • 3. The impact of preoperative biologic therapy on anastomotic complications after surgery for Crohn's disease.
    Yamamoto T, Shiraki M.
    Scand J Gastroenterol; 2012 Dec; 47(12):1521-2. PubMed ID: 22809295
    [No Abstract] [Full Text] [Related]

  • 4. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 5. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
    Nørgård BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OB, Kjeldsen J.
    Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
    [Abstract] [Full Text] [Related]

  • 6. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
    Myrelid P, Marti-Gallostra M, Ashraf S, Sunde ML, Tholin M, Oresland T, Lovegrove RE, Tøttrup A, Kjaer DW, George BD.
    Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
    Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ.
    J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048
    [Abstract] [Full Text] [Related]

  • 8. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
    Shental O, Tulchinsky H, Greenberg R, Klausner JM, Avital S.
    Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.
    Kanazawa A, Yamana T, Okamoto K, Sahara R.
    Dis Colon Rectum; 2012 Sep; 55(9):957-62. PubMed ID: 22874602
    [Abstract] [Full Text] [Related]

  • 10. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
    Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD.
    Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
    [Abstract] [Full Text] [Related]

  • 11. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
    Klein M.
    Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097
    [Abstract] [Full Text] [Related]

  • 12. A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery.
    Zuo L, Li Y, Wang H, Zhu W, Zhang W, Gong J, Li N, Li J.
    Dis Colon Rectum; 2015 Aug; 58(8):775-81. PubMed ID: 26163957
    [Abstract] [Full Text] [Related]

  • 13. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery.
    Resegotti A, Astegiano M, Farina EC, Ciccone G, Avagnina G, Giustetto A, Campra D, Fronda GR.
    Dis Colon Rectum; 2005 Mar; 48(3):464-8. PubMed ID: 15719193
    [Abstract] [Full Text] [Related]

  • 14. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
    Tzivanakis A, Singh JC, Guy RJ, Travis SP, Mortensen NJ, George BD.
    Dis Colon Rectum; 2012 May; 55(5):558-62. PubMed ID: 22513434
    [Abstract] [Full Text] [Related]

  • 15. Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn's disease: who is at risk?
    Riss S, Bittermann C, Zandl S, Kristo I, Stift A, Papay P, Vogelsang H, Mittlböck M, Herbst F.
    Colorectal Dis; 2010 Oct; 12(10 Online):e298-303. PubMed ID: 20041915
    [Abstract] [Full Text] [Related]

  • 16. [Inflammatory bowel diseases--new therapeutic options].
    Herrlinger K, Stange EF.
    Med Klin (Munich); 2008 Feb 15; 103(2):90-101; quiz 102-3. PubMed ID: 18270665
    [No Abstract] [Full Text] [Related]

  • 17. Sequential therapies for Crohn's disease: optimizing conventional and biologic strategies.
    Desilva S, Kaplan G, Panaccione R.
    Rev Gastroenterol Disord; 2008 Feb 15; 8(2):109-16. PubMed ID: 18641593
    [Abstract] [Full Text] [Related]

  • 18. Maintenance therapy with certolizumab pegol for Crohn's disease.
    Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OØ, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ, PRECISE 2 Study Investigators.
    N Engl J Med; 2007 Jul 19; 357(3):239-50. PubMed ID: 17634459
    [Abstract] [Full Text] [Related]

  • 19. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
    August DA, Serrano D, Poplin E.
    J Surg Oncol; 2008 Feb 01; 97(2):180-5. PubMed ID: 18095268
    [Abstract] [Full Text] [Related]

  • 20. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
    Nørgård BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OB, Kjeldsen J.
    Aliment Pharmacol Ther; 2012 Jun 01; 35(11):1301-9. PubMed ID: 22506582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.